Biovie (BIVIW) Stock Price, News & Analysis
Company Description
Biovie (NASDAQ: BIVIW) is classified in the Pharmaceutical Preparations sector.
BIVIW has declined 3.5% over the past year. Shares last traded at $0.3600.
For FY2026, Biovie reported net income of -$22.1M and diluted earnings per share of -$3.05.
This page collects what Stock Titan holds for BIVIW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Biovie (BIVIW) stock last closed at $0.3600. Over the past 12 months, the stock has lost 3.5%.
BIVIW Rankings
Latest News
SEC Filings
Biovie has filed 5 recent SEC filings, including 4 Form 4, 1 Form SCHEDULE 13G. The most recent filing was submitted on September 3, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BIVIW SEC filings →
Financial Highlights
operating income reached -$22.7M, and net income was -$22.1M. Diluted earnings per share stood at -$3.05. The company generated -$19.0M in operating cash flow. With a current ratio of 3.59, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Biovie (BIVIW) currently stands at 536.7 thousand shares, a new position with no short interest reported in the previous period. Since September 2025, short interest has increased by 12034.2%.
Days to Cover History
Days to cover for Biovie (BIVIW) currently stands at 1.4 days, up 39% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 27.5% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 6.2 days.
BIVIW Company Profile & Sector Positioning
Biovie (BIVIW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.